We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.25 | 0.60% | 42.25 | 42.00 | 42.50 | 42.25 | 41.75 | 42.25 | 75,298 | 15:29:20 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 103.05 | 53.16M |
From Apr 2019 to Apr 2024
TIDMVLG
RNS Number : 1206J
Venture Life Group PLC
07 September 2016
7 September 2016
Venture Life Group plc
("Venture Life" or the "Group")
Notice of Interim Results
Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, will announce its Interim Results for the six months ended 30 June 2016 on 21 September 2016.
A briefing for analysts will take place at the offices of Walbrook PR, 4 Lombard St., London EC3V 9HD at 9.30am on Wednesday 21 September 2016.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email venturelife@walbrookpr.com.
For further information, please contact:
Hot Features
Premium
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive
Officer
James Hunter, Chief Financial
Officer
Panmure Gordon (UK) Limited (Nominated +44 (0) 20 7886
Adviser and Broker) 2500
Freddy Crossley/Peter Steel/Duncan
Monteith (Corporate Finance)
Tom Salvesen (Corporate Broking)
Walbrook PR venturelife@walbrookpr.com
or
+44 (0) 20 7933 8780
+44 (0) 7980 541
Paul McManus 994
+44 (0) 7876 741
Anna Dunphy 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.
The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREQLFBQKFXBBV
(END) Dow Jones Newswires
September 07, 2016 02:01 ET (06:01 GMT)
1 Year Venture Life Chart |
1 Month Venture Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
